MS drug withdrawn after patient dies

IRISH drugs group Elan and its partner Biogen have withdrawn sales of its multiple sclerosis drugs after a patient died from the rare and often fatal central nervous system disease, sending shares of both drug makers tumbling.

A second patient is also in danger.

One patient was 38 months on the drug and the other 27.